Chang Ming Charlie

Fox Chase Cancer Center

Papers

1

Total Citations

11

H-Index

1

About

Dr. Chang Ming Charlie is a leading medical physicist whose research centers on advancing stereotactic radiosurgery and radiotherapy (SRS/SBRT), with a particular focus on liver cancer treatment. His major contributions lie in optimizing dosimetric quality and delivery efficiency for complex radiation systems. In his highly cited 2016 study, Dr. Charlie investigated the novel CyberKnife M6 system equipped with a multileaf collimator (MLC), demonstrating how this technology can extend robotic radiosurgery capabilities to conventionally fractionated radiotherapy. His work provided critical insights into plan quality for hepatic lesions, showing that MLC-based delivery could achieve comparable dosimetric results while significantly reducing treatment times. This research has been instrumental in bridging the gap between radiosurgery and conventional radiotherapy, cited 11 times by peers seeking to improve clinical workflow. Dr. Charlie’s pioneering efforts have helped establish new standards for treating liver tumors with hybrid robotic systems, directly impacting patient care by making precise, non-invasive treatments more accessible and efficient.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Dosimetric and delivery efficiency investigation for treating hepatic lesions with a MLC‐equipped robotic radiosurgery–radiotherapy combined system
11 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Fox Chase Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago